Motif Investing’s “Fighting Ebola” stock basket as of Oct. 21 Company/Ticker Segment Weight at Oct. 21 close Performance MTD NewLink Genetics NLNK, +9.73% Drug & Vaccines 5.66% 61.1% Sarepta Therapeutics SRPT, -1.49% Drug & Vaccines 4.26% 6.6% BioCryst Pharmaceuticals BCRX, -1.98% Drug & Vaccines 3.90% 16.3% Amgen AMGN, +4.79% Drug & Vaccines 3.90% 2.6% Inovio Pharmaceuticals INO, -5.25% Drug & Vaccines 3.78% 17.3% Chimerix CMRX, -1.37% Drug & Vaccines 3.72% 9.5% Johnson & Johnson JNJ, +1.17% Drug & Vaccines 3.70% -5.9% Neogen NEOG, +2.24% Drug & Vaccines 3.67% 7.4% GlaxoSmtihKline GSK, +0.05% Drug & Vaccines 3.57% -5.1% NanoViricides NNVC, +2.81% Drug & Vaccines 3.55% 22% Tekmira Pharmaceuticals TKMR, -3.39% Drug & Vaccines 2.73% -17% Ecolab ECL, +2.50% Protective Equipment 3.77% -1.9% 3M MMM, +2.42% Protective Equipment 3.76% -0.5% DuPont DD, +1.49% Protective Equipment 3.74% -4.1% Kimberly-Clark KMB, +2.95% Protective Equipment 3.74% 3.4% Cantel Medical CMN, -0.55% Protective Equipment 3.54% 10.2% Lakeland Industries Protective Equipment 2.49% 115% Alpha Pro Tech Protective Equipment 2.29% 44.6% Luminex LMNX, +1.28% Diagnostics 3.34% 1.1% ProShares UltraShort Russell2000 Market Hedge 30.90% -3.1% http://www.marketwatch.com/story/fighting-ebola-though-investing-one-firms-approach-2014-10-21?mod=MethodeStories&link=sfmw